Trgovina Unicycive Therapeutics, Inc. - UNCY CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Razmik | 0.07 | ||||||||
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.025457% | ||||||||
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | 0.003235% | ||||||||
Čas nočne pristojbine | 21:00 (UTC) | ||||||||
Min. tržena količina | 1 | ||||||||
Valuta | USD | ||||||||
Kritje | 20% | ||||||||
Borza | United States of America | ||||||||
Provizija na trgovanje | 0% |
*Information provided by Capital.com
Predhodno. Zapri* | 1.33 |
Odpri* | 1.33 |
Enoletna sprememba* | 64.2% |
Dnevni razpon* | 1.31 - 1.33 |
Razpon 52 wk | 0.40-2.87 |
Povprečni obseg (10 dni) | 139.61K |
Povprečni obseg (3 meseci) | 121.72M |
Tržna kapitalizacija | 20.57M |
Razmerje P/E | -100.00K |
Število delnic v obtoku | 15.23M |
Prihodki | 1.63M |
EPS | -1.93 |
Dividenda (donosnost v %) | N/A |
Beta | -100.00K |
Datum naslednjega zaslužka | N/A |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
---|---|---|---|---|---|---|
May 30, 2023 | 1.33 | 0.00 | 0.00% | 1.33 | 1.36 | 1.32 |
May 26, 2023 | 1.33 | -0.03 | -2.21% | 1.36 | 1.39 | 1.31 |
May 25, 2023 | 1.41 | 0.05 | 3.68% | 1.36 | 1.41 | 1.36 |
May 24, 2023 | 1.40 | 0.05 | 3.70% | 1.35 | 1.41 | 1.35 |
May 23, 2023 | 1.35 | 0.01 | 0.75% | 1.34 | 1.40 | 1.31 |
May 22, 2023 | 1.34 | -0.01 | -0.74% | 1.35 | 1.39 | 1.31 |
May 19, 2023 | 1.33 | -0.04 | -2.92% | 1.37 | 1.37 | 1.31 |
May 18, 2023 | 1.37 | 0.03 | 2.24% | 1.34 | 1.41 | 1.34 |
May 17, 2023 | 1.36 | 0.07 | 5.43% | 1.29 | 1.37 | 1.22 |
May 16, 2023 | 1.31 | -0.09 | -6.43% | 1.40 | 1.40 | 1.30 |
May 15, 2023 | 1.37 | -0.05 | -3.52% | 1.42 | 1.42 | 1.34 |
May 12, 2023 | 1.34 | -0.07 | -4.96% | 1.41 | 1.47 | 1.33 |
May 11, 2023 | 1.45 | -0.03 | -2.03% | 1.48 | 1.51 | 1.37 |
May 10, 2023 | 1.47 | 0.00 | 0.00% | 1.47 | 1.54 | 1.41 |
May 9, 2023 | 1.50 | 0.07 | 4.90% | 1.43 | 1.52 | 1.36 |
May 8, 2023 | 1.43 | 0.10 | 7.52% | 1.33 | 1.46 | 1.30 |
May 5, 2023 | 1.32 | 0.07 | 5.60% | 1.25 | 1.39 | 1.24 |
May 4, 2023 | 1.29 | 0.13 | 11.21% | 1.16 | 1.34 | 1.16 |
May 3, 2023 | 1.22 | -0.01 | -0.81% | 1.23 | 1.28 | 1.21 |
May 2, 2023 | 1.24 | -0.07 | -5.34% | 1.31 | 1.31 | 1.21 |
Unicycive Therapeutics, Inc. Events
Čas (UTC) (UTC) | Država | Dogodek |
---|---|---|
No events scheduled |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Skupni prihodki | 0.951 | 0 | 0 | 0 | 0 |
Celotni odhodki iz poslovanja | 19.003 | 8.958 | 2.02 | 1.963 | 0.952 |
Celotna prodaja/splošni/upravni stroški Odhodki | 6.567 | 2.897 | 1.005 | 1.168 | 0.608 |
Raziskave in razvoj | 12.436 | 6.08 | 1.015 | 0.795 | 0.344 |
Prihodki iz poslovanja | -18.052 | -8.958 | -2.02 | -1.963 | -0.952 |
Prihodki (odhodki) od obresti, neto Neoperativni | -0.006 | -0.628 | -0.244 | -0.139 | -0.168 |
Drugo, neto | 0 | -0.431 | 0 | -0.063 | 0 |
Čisti dobiček pred obdavčitvijo | -18.058 | -10.017 | -2.264 | -2.165 | -1.12 |
Čisti dobiček po davkih | -18.058 | -10.017 | -2.264 | -2.165 | -1.12 |
Čisti dobiček pred dodatnimi postavkami | -18.058 | -10.017 | -2.264 | -2.165 | -1.12 |
Čisti dobiček | -18.058 | -10.017 | -2.264 | -2.165 | -1.12 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -18.058 | -10.017 | -2.264 | -2.165 | -1.12 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -18.058 | -10.017 | -2.264 | -2.165 | -1.12 |
Popravljen čisti dobiček | -18.058 | -10.017 | -2.264 | -2.165 | -1.12 |
Popravljene ponderirane povprečne delnice | 15.057 | 14.9965 | 14.4969 | 14.4969 | 14.4969 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -1.19931 | -0.66795 | -0.15617 | -0.14934 | -0.07726 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
Popravljen normalizirani dobiček na enoto čistega dobička | -1.19931 | -0.66922 | -0.15617 | -0.14934 | -0.07726 |
Nenavadni odhodki (prihodki) | 0 | -0.019 | 0 | 0 | |
Prihodki | 0.951 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Skupni prihodki | 0.675 | 0 | 0.951 | 0 | 0 |
Celotni odhodki iz poslovanja | 4.877 | 5.325 | 6.505 | 3.636 | 3.537 |
Celotna prodaja/splošni/upravni stroški Odhodki | 1.847 | 1.485 | 1.702 | 1.776 | 1.604 |
Raziskave in razvoj | 3.03 | 3.84 | 4.803 | 1.86 | 1.933 |
Nenavadni odhodki (prihodki) | 0 | 0 | 0 | 0 | |
Prihodki iz poslovanja | -4.202 | -5.325 | -5.554 | -3.636 | -3.537 |
Prihodki (odhodki) od obresti, neto Neoperativni | 0.002 | -0.003 | -0.003 | 0 | 0 |
Drugo, neto | -10.375 | 0 | 0 | ||
Čisti dobiček pred obdavčitvijo | -14.575 | -5.328 | -5.557 | -3.636 | -3.537 |
Čisti dobiček po davkih | -14.575 | -5.328 | -5.557 | -3.636 | -3.537 |
Čisti dobiček pred dodatnimi postavkami | -14.575 | -5.328 | -5.557 | -3.636 | -3.537 |
Čisti dobiček | -14.575 | -5.328 | -5.557 | -3.636 | -3.537 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -14.767 | -5.328 | -5.557 | -3.636 | -3.537 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -14.767 | -5.328 | -5.557 | -3.636 | -3.537 |
Popravljen čisti dobiček | -14.767 | -5.328 | -5.557 | -3.636 | -3.537 |
Popravljene ponderirane povprečne delnice | 15.2324 | 15.077 | 15.062 | 15.0287 | 15.0046 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.96945 | -0.35339 | -0.36894 | -0.24194 | -0.23573 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Popravljen normalizirani dobiček na enoto čistega dobička | -0.96945 | -0.35339 | -0.36894 | -0.24194 | -0.23573 |
Prihodki | 0.675 | 0 | 0.951 | ||
Total Adjustments to Net Income | -0.192 |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 2.644 | 18.411 | 0.204 | 0.019 | 0.029 |
Denarna sredstva in kratkoročne naložbe | 0.455 | 16.579 | 0 | 0.015 | 0.025 |
Cash | 0.455 | 16.579 | 0 | 0.015 | 0.025 |
Prepaid Expenses | 2.189 | 1.832 | 0.004 | 0.004 | 0.004 |
Other Current Assets, Total | 0.2 | 0 | 0 | ||
Total Assets | 2.818 | 18.744 | 0.204 | 0.019 | 0.029 |
Total Current Liabilities | 3.284 | 2.105 | 2.875 | 0.903 | 1.235 |
Accounts Payable | 0.892 | 0.742 | 0.184 | 0.322 | 0.06 |
Accrued Expenses | 2.392 | 1.363 | 0.168 | 0.013 | 0.017 |
Notes Payable/Short Term Debt | 0 | 0 | 0.986 | 0.46 | 0.147 |
Current Port. of LT Debt/Capital Leases | 0 | 1.528 | 0 | 0.9 | |
Other Current Liabilities, Total | 0 | 0.009 | 0.108 | 0.111 | |
Total Liabilities | 3.284 | 2.26 | 2.875 | 0.903 | 1.235 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Equity | -0.466 | 16.484 | -2.671 | -0.884 | -1.206 |
Common Stock | 0.015 | 0.015 | 0.037 | 0.036 | 0.034 |
Additional Paid-In Capital | 33.516 | 32.408 | 3.214 | 2.738 | 0.253 |
Retained Earnings (Accumulated Deficit) | -33.997 | -15.939 | -5.922 | -3.658 | -1.493 |
Total Liabilities & Shareholders’ Equity | 2.818 | 18.744 | 0.204 | 0.019 | 0.029 |
Total Common Shares Outstanding | 15.2317 | 14.9965 | 14.4969 | 14.4969 | 14.4969 |
Property/Plant/Equipment, Total - Net | 0.174 | 0.333 | |||
Property/Plant/Equipment, Total - Gross | 0.181 | 0.334 | |||
Accumulated Depreciation, Total | -0.007 | -0.001 | |||
Other Liabilities, Total | 0 | 0.155 | |||
Preferred Stock - Non Redeemable, Net | 0 | 0 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 26.184 | 2.644 | 9.962 | 12.56 | 15.464 |
Denarna sredstva in kratkoročne naložbe | 24.332 | 0.455 | 7.01 | 10.573 | 13.62 |
Cash | 24.332 | 0.455 | 7.01 | 10.573 | 13.62 |
Prepaid Expenses | 1.852 | 2.189 | 2.952 | 1.987 | 1.844 |
Other Current Assets, Total | |||||
Total Assets | 27.202 | 2.818 | 10.177 | 12.816 | 15.76 |
Total Current Liabilities | 15.97 | 3.284 | 5.522 | 2.834 | 2.402 |
Accounts Payable | 0.79 | 0.892 | 2.292 | 0.747 | 0.589 |
Accrued Expenses | 1.974 | 2.392 | 3.23 | 2.087 | 1.813 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | |||||
Other Current Liabilities, Total | 13.206 | ||||
Total Liabilities | 16.685 | 3.284 | 5.551 | 2.906 | 2.516 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Equity | 10.517 | -0.466 | 4.626 | 9.91 | 13.244 |
Common Stock | 0.015 | 0.015 | 0.015 | 0.015 | 0.015 |
Additional Paid-In Capital | 33.475 | 33.516 | 33.28 | 33.007 | 32.705 |
Retained Earnings (Accumulated Deficit) | -48.572 | -33.997 | -28.669 | -23.112 | -19.476 |
Total Liabilities & Shareholders’ Equity | 27.202 | 2.818 | 10.177 | 12.816 | 15.76 |
Total Common Shares Outstanding | 15.2338 | 15.2317 | 15.0879 | 15.0445 | 15.0205 |
Property/Plant/Equipment, Total - Net | 1.018 | 0.174 | 0.215 | 0.256 | 0.296 |
Other Liabilities, Total | 0.715 | 0 | 0.029 | 0.072 | 0.114 |
Preferred Stock - Non Redeemable, Net | 25.599 | 0 | 0 | 0 | 0 |
Property/Plant/Equipment, Total - Gross | 1.026 | 0.181 | 0.221 | 0.26 | 0.299 |
Accumulated Depreciation, Total | -0.008 | -0.007 | -0.006 | -0.004 | -0.003 |
- Letni
- Četrtletno
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Čisti prihodki/začetna postavka | -18.058 | -10.017 | -2.264 | -2.165 | -1.12 |
Denarna sredstva iz poslovanja | -15.651 | -5.767 | -1.459 | -1.176 | -0.775 |
Nedenarne postavke | 1.222 | 4.354 | 0.971 | 0.684 | 0.339 |
Cash Taxes Paid | 0 | 0 | 0.001 | 0.002 | 0 |
Spremembe v obratnem kapitalu | 1.178 | -0.105 | -0.166 | 0.305 | 0.006 |
Denarna sredstva pri financiranju | -0.471 | 22.375 | 1.444 | 1.166 | 0.8 |
Postavke denarnega toka pri financiranju | -0.482 | 0 | -0.117 | 0 | 0 |
Izdaja (odplačilo) delnic, neto | 0.011 | 22.39 | 0.141 | 1.166 | 0.25 |
Izdaja (odplačilo) dolga, neto | 0 | -0.015 | 1.42 | 0 | 0.55 |
Neto sprememba denarnih sredstev | -16.124 | 16.579 | -0.015 | -0.01 | 0.025 |
Denarna sredstva iz poslovanja | 0.007 | 0.001 | |||
Denarna sredstva pri naložbenju | -0.002 | -0.029 | |||
Kapitalski izdatki | -0.002 | -0.029 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -14.575 | -18.058 | -12.73 | -7.173 | -3.537 |
Cash From Operating Activities | -3.92 | -15.651 | -9.567 | -6.004 | -2.957 |
Non-Cash Items | 10.562 | 1.222 | 0.964 | 0.659 | 0.327 |
Cash Taxes Paid | 0 | 0 | 0 | 0 | |
Changes in Working Capital | 0.091 | 1.178 | 2.194 | 0.506 | 0.251 |
Cash From Financing Activities | 27.797 | -0.471 | 0 | 0 | 0 |
Financing Cash Flow Items | -0.24 | -0.482 | 0 | ||
Issuance (Retirement) of Stock, Net | 28.037 | 0.011 | 0 | 0 | 0 |
Issuance (Retirement) of Debt, Net | 0 | 0 | 0 | 0 | |
Net Change in Cash | 23.877 | -16.124 | -9.569 | -6.006 | -2.959 |
Cash From Operating Activities | 0.002 | 0.007 | 0.005 | 0.004 | 0.002 |
Cash From Investing Activities | 0 | -0.002 | -0.002 | -0.002 | -0.002 |
Capital Expenditures | 0 | -0.002 | -0.002 | -0.002 | -0.002 |
Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
---|---|---|---|---|---|---|
Gupta (Shalabh K) | Individual Investor | 38.5251 | 5868849 | 33906 | 2023-04-27 | |
Armistice Capital LLC | Hedge Fund | 6.4068 | 976000 | 176000 | 2022-12-31 | HIGH |
Rosalind Advisors, Inc. | Hedge Fund | 6.364 | 969484 | 0 | 2023-04-27 | |
Balyasny Asset Management LP | Hedge Fund | 4.7089 | 717349 | 717349 | 2023-03-31 | HIGH |
Nantahala Capital Management, LLC | Hedge Fund | 4.2499 | 647416 | 0 | 2023-03-31 | LOW |
Altium Growth GP, LLC | Corporation | 1.1553 | 176000 | 176000 | 2021-12-31 | |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 0.7553 | 115057 | 92362 | 2023-03-31 | LOW |
Laumas (Sandeep) | Individual Investor | 0.6946 | 105815 | 0 | 2023-04-27 | |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.6295 | 95898 | 69789 | 2023-03-31 | LOW |
Jermasek (Douglas) | Individual Investor | 0.4621 | 70400 | 0 | 2023-04-27 | LOW |
Ryan (John L) | Individual Investor | 0.3817 | 58140 | 0 | 2023-04-27 | |
Schiller (Brigitte) | Individual Investor | 0.274 | 41738 | 0 | 2023-04-27 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.23 | 35036 | 35036 | 2023-03-31 | LOW |
Frontier Wealth Management LLC | Investment Advisor | 0.1234 | 18800 | 0 | 2022-06-30 | HIGH |
CAPTRUST Financial Advisors | Investment Advisor | 0.1234 | 18800 | 18800 | 2023-03-31 | LOW |
Tandem Capital Management, Inc. | Investment Advisor | 0.1017 | 15500 | 0 | 2023-03-31 | LOW |
Two Sigma Investments, LP | Hedge Fund | 0.0958 | 14600 | 14600 | 2023-03-31 | HIGH |
Oxbow Advisors, LLC | Investment Advisor | 0.0779 | 11861 | 11861 | 2023-03-31 | LOW |
Squarepoint Capital LLP | Investment Advisor/Hedge Fund | 0.0752 | 11459 | 11459 | 2023-03-31 | HIGH |
Tower Research Capital LLC | Hedge Fund | 0.0224 | 3419 | -1577 | 2023-03-31 | HIGH |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group530K+
Borzni posredniki
87K+
Aktivne stranke mesečno
$46M+
Mesečni obseg naložb
$31M+
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Unicycive Therapeutics, Inc. Company profile
O družbi Unicycive Therapeutics, Inc.
Unicycive Therapeutics, Inc. je biotehnološko podjetje, ki se ukvarja z razvojem zdravil za določena zdravstvena stanja. Družba se osredotoča na ugotavljanje zdravstvenih stanj znotraj in zunaj bolezni ledvic. Njeni razvojni programi so usmerjeni v razvoj dveh terapij: Renazorb za zdravljenje hiperfosfatemije pri bolnikih s kronično ledvično boleznijo in UNI 494 za zdravljenje akutne poškodbe ledvic (AKI). Renazorb je prvotno razvila družba Spectrum Pharmaceuticals, ki je zanj pridobila licenco. UNI 494 je prvotno razvila družba Sphaera Pharmaceuticals, ki je zanj pridobila licenco.
Industry: | Biotechnology & Medical Research (NEC) |
4300 El Camino Real, Suite 210
LOS ALTOS
CALIFORNIA 94022
US
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 530.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com